Suzanne E. Schindler, MD

Research Interests

Dr. Suzanne Schindler completed the MD/PhD program at Washington University in the laboratory of Dr. David Holtzman. Her thesis was on brain metabolism of apolipoprotein E (apoE), a lipoprotein that modifies risk for Alzheimer disease. Dr. Schindler trained in clinical neurology and dementia under the mentorship of Drs. John Morris and Marc Diamond. She joined the neurology faculty of Washington University and the laboratory of Dr. Anne Fagan in 2014. She has been involved in clinical trials for Alzheimer disease, including the first prevention drug trial for Alzheimer disease. Dr. Schindler received a K23 career development award from the National Institute on Aging to study fluid biomarkers of Alzheimer disease. She has been working with Dr. Randall Bateman on developing blood tests for Alzheimer disease. The primary focus of her work is using fluid biomarkers to predict if and when cognitively normal individuals will develop symptoms of Alzheimer disease dementia.